Balance Sheet
Accounts PayablesAccumulated DepreciationAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fortress Biotech (FBIO) Total Current Liabilities (2016 - 2025)

Fortress Biotech has reported Total Current Liabilities over the past 13 years, most recently at $49.7 million for Q4 2025.

  • Quarterly results put Total Current Liabilities at $49.7 million for Q4 2025, down 30.33% from a year ago — trailing twelve months through Dec 2025 was $49.7 million (down 30.33% YoY), and the annual figure for FY2025 was $49.7 million, down 30.33%.
  • Total Current Liabilities for Q4 2025 was $49.7 million at Fortress Biotech, down from $54.1 million in the prior quarter.
  • Over the last five years, Total Current Liabilities for FBIO hit a ceiling of $129.5 million in Q1 2023 and a floor of $49.7 million in Q4 2025.
  • Median Total Current Liabilities over the past 5 years was $86.3 million (2023), compared with a mean of $87.6 million.
  • Biggest five-year swings in Total Current Liabilities: soared 176.85% in 2021 and later tumbled 41.25% in 2024.
  • Fortress Biotech's Total Current Liabilities stood at $101.0 million in 2021, then increased by 26.4% to $127.7 million in 2022, then plummeted by 33.52% to $84.9 million in 2023, then decreased by 15.91% to $71.4 million in 2024, then crashed by 30.33% to $49.7 million in 2025.
  • The last three reported values for Total Current Liabilities were $49.7 million (Q4 2025), $54.1 million (Q3 2025), and $57.5 million (Q2 2025) per Business Quant data.